This Notice of Funding Opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials related to the research mission of the NIAID.
This program provides support for
hypothesis-driven, milestone-driven clinical trials.
Although clinical trials not considered high-risk may be proposed, this program encourages high-risk clinical studies.
High- risk does not imply human subject or patient risk, but rather defines a study that contains one or more of the following unique features:
involves non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication.
Mechanistic studies are also encouraged and may be proposed under this program.